2019 Early Investigator Prize winners
Jean-Philippe Leduc-Gaudet awarded the Journal of Physiology’s 2019 Early Investigator prize.
According to the WHO, respiratory disorders are leading causes of death world-wide (second only to heart attack & stroke). These include diseases such as obstructive lung diseases and pulmonary infections. As a result, our research is focused around four main pulmonary research themes. These include: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, and sleep-disordered breathing.
Above all, a multidisciplinary approach is used to study the basic mechanisms of a number of diseases. These include asthma, chronic obstructive pulmonary disease, pulmonary infections, cystic fibrosis, sleep apnea, respiratory muscle disorders, pulmonary fibrosis, lung injury, and rare respiratory diseases. Research at the Meakins also involves the study of human physiology and tissues in parallel with relevant animal and cell culture models. Furthermore, research is facilitated by the availability of a variety of core facilities for both clinical and fundamental studies.
Learn more about our research themes here.
Below you will see posts and news items related to our research themes.
Jean-Philippe Leduc-Gaudet awarded the Journal of Physiology’s 2019 Early Investigator prize.
Dr. Maziar Divangahi asserts that only a team effort across scientific disciplines will lead to the elimination of SARS-CoV-2.
Dr. Menzies was awarded the Canada Research Chair in Tuberculosis, Tier 1, in the Spring 2019 round.
Thanks to Adomo Donovan and the ICU Bridge Program, the MUHC’s ICU staff are now recognizable despite their PPE.
Dr. Menzies’ study found that 4-months of rifampin is a better course of treatment and more cost-effective for latent TB.
A new clinical trial, designed by Drs. Ezer, Martin, Benedetti & Smith, will test ciclesonide in the early stages of COVID-19.
Dr. Jean Bourbeau receives funding from the CIHR COVID-19 Rapid Research Funding Opportunity.
Publication by Dr. Benjamin Smith in JAMA highlights a new risk factor for COPD related to lung development
Read an opinion piece by Dr. Dick Menzies: How to focus testing and help eliminate the spread of COVID-19.
Dr. Dick Menzies calls for a more extensive and ultimately less expensive approach to COVID-19 testing for all Canadians.